Cargando…
Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing–Based NTRK Fusion Detection in South Korea
PURPOSE: Tropomyosin receptor kinase (TRK) inhibitors are approved for the treatment of neurotrophic receptor tyrosine kinase (NTRK) fusion-positive tumors. The detection of NTRK fusion using a validated method is required before therapeutic application. An interlaboratory comparison study of next-g...
Autores principales: | Lee, Seung Eun, Lee, Mi-Sook, Jeon, Yoon Kyung, Shim, Hyo Sup, Kang, Jun, Kim, Jihun, Choi, Yoon-La |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873325/ https://www.ncbi.nlm.nih.gov/pubmed/35167738 http://dx.doi.org/10.4143/crt.2021.1572 |
Ejemplares similares
-
NTRK Fusions in 1113 Solid Tumors in a Single Institution
por: Bang, Heejin, et al.
Publicado: (2022) -
Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
por: Kang, Jeongwan, et al.
Publicado: (2020) -
NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014) -
High Interlaboratory Reproducibility and Accuracy of Next-Generation-Sequencing-Based Bacterial Genotyping in a Ring Trial
por: Mellmann, Alexander, et al.
Publicado: (2017) -
Identifying patients with NTRK fusion cancer
por: Solomon, J P, et al.
Publicado: (2019)